Mónica Hernández Alava

All publications

Journal articles

• Maslyankov I & Hernández M (2024) The prevalence and determinants of unmet healthcare needs in Bulgaria. PLOS ONE, 19(10), e0312475-e0312475.
• Squires H, Kelly MP, Gilbert N, Sniehotta F, Purshouse RC, Garcia L, Breeze P, Brennan A, Gardner B, Bright S , Fischer A et al (2024) The PHEM-B toolbox of methods for incorporating the influences on behaviour into public health economic models. BMC Public Health, 24(1). View this article in WRRO
• Pennington BM, Alava MH & Strong M (2024) Unpaid caring and heath-related quality of life: longitudinal analysis of understanding society (the UK household longitudinal survey). Value in Health. View this article in WRRO
• Holmes J, Sasso A, Hernández Alava M, Borges Neves R, Stevely AK, Warde A & Meier PS (2024) How is alcohol consumption and heavy episodic drinking spread across different types of drinking occasion in Great Britain: An event-level latent class analysis. International Journal of Drug Policy, 127. View this article in WRRO
• Hnynn Si PE, Hernández-Alava M, Dunn L, Wilkie M & Fotheringham J (2023) The trajectory of a range of commonly captured symptoms with standard care in people with kidney failure receiving haemodialysis: consideration for clinical trial design. BMC Nephrology, 24(1). View this article in WRRO
• Holmes J, Sasso A, Hernández Alava M, Stevely AK, Warde A, Angus C & Meier PS (2023) Change and stability in british drinking practices and culture between 2009 and 2019: a longitudinal latent class analysis of drinking occasions.. SSM - Population Health. View this article in WRRO
• Stevely AK, Mackay D, Alava MH, Brennan A, Meier PS, Sasso A & Holmes J (2023) Evaluating the effects of minimum unit pricing in Scotland on the prevalence of harmful drinking: a controlled interrupted time series analysis. Public Health, 220, 43-49.
• Si PEH, Hernandez M, Sasso A, Gittus M, Powell R, Dunn L & Fotheringham J (2023) #5510 CKD-ASSOCIATED PRURITUS SEVERITY AND ITS ASSOCIATION WITH BODY DISTRIBUTION AND EQ-5D HEALTH-RELATED QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS. Nephrology Dialysis Transplantation, 38(Supplement_1).
• Breeze PR, Squires H, Ennis K, Meier P, Hayes K, Lomax N, Shiell A, Kee F, de Vocht F, O’Flaherty M , Gilbert N et al (2023) Guidance on the use of complex systems models for economic evaluations of public health interventions. Health Economics.
• Bowen JM, Hernandez M, Johnson DS, Green C, Kammin T, Baker D, Keigwin S, Makino S, Taylor N, Watson O , Wheeldon NM et al (2023) Diagnosis and management of vascular Ehlers-Danlos syndrome: experience of the UK national diagnostic service, Sheffield. European Journal of Human Genetics.
• Warde A, Sasso A, Holmes J, Hernandez Alava M, Stevely A & Meier P (2023) Situated drinking: the association between eating and alcohol consumption in Great Britain. Nordic Studies on Alcohol and Drugs.
• Tappenden P, Navega Biz A, Hernández Alava M, Sasso A, Sutton L, Ennis K, Elliott R & Wildman M (2023) A model-based economic analysis of the CFHealthHub intervention to support adherence to inhaled medications for people with cystic fibrosis in the UK. International Journal of Technology Assessment in Health Care, 39(1).
• Hernández Alava M, Pudney S & Wailoo A (2023) Estimating the relationship between EQ-5D-5L and EQ-5D-3L: results from a UK population study. PharmacoEconomics, 41(2), 199-207.
• Gray LA, Hernandez Alava M & Wailoo AJ (2022) Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer. BMC Cancer, 22(1).
• Holmes J, Sasso A, Alava MH, Neves RB, Stevely AK, Warde A & Meier PS (2022) The distribution of alcohol consumption and heavy episodic drinking across British drinking occasions in 2019: a cross-sectional, latent, class analysis of event-level drinking diary data.. Lancet, 400 Suppl 1, S50.
• Sasso A, Hernández-Alava M, Holmes J, Field M, Angus C & Meier P (2022) Strategies to cut down drinking, alcohol consumption, and usual drinking frequency : evidence from a British online market research survey. Social Science & Medicine, 310. View this article in WRRO
• Hernandez M & Pudney S (2022) Mapping between EQ-5D-3L and EQ-5D-5L: A survey experiment on the validity of multi-instrument data. Health Economics. View this article in WRRO
• Wildman MJ, O’Cathain A, Hind D, Maguire C, Arden MA, Hutchings M, Bradley J, Walters SJ, Whelan P, Ainsworth J , Tappenden P et al (2021) An intervention to support adherence to inhaled medication in adults with cystic fibrosis : the ACtiF research programme including RCT. Programme Grants for Applied Research, 9(11), 1-146. View this article in WRRO
• Opazo Breton M, Gillespie D, Pryce R, Bogdanovica I, Angus C, Hernandez Alava M, Brennan A & Britton J (2021) Understanding long‐term trends in smoking in England, 1972‐2019 : an age‐period‐cohort approach. Addiction. View this article in WRRO
• Wailoo A, Alava MH, Pudney S, Barton G, O’Dwyer J, Gomes M, Irvine L, Meads D & Sadique Z (2021) An international comparison of EQ-5D-5L and EQ-5D-3L for use in cost-effectiveness analysis. Value in Health, 24(4), 568-574. View this article in WRRO
• Pennington BM, Hernández-Alava M, Hykin P, Sivaprasad S, Flight L, Alshreef A & Brazier J (2020) Mapping from visual acuity to EQ-5D, EQ-5D with vision bolt-on, and VFQ-UI in patients with macular edema in the LEAVO trial. Value in Health. View this article in WRRO
• Hernandez Alava M, Pudney S & Wailoo A (2020) The EQ-5D-5L value set for England: Findings of a quality assurance program. Value in Health. View this article in WRRO
• Kiadaliri A, Alava MH, Roos EM & Englund M (2019) Mapping EQ-5D-3L from the knee injury and osteoarthritis outcome score (KOOS). Quality of Life Research. View this article in WRRO
• Gray LA, Wailoo A & Hernandez M (2018) Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping. Value in Health. View this article in WRRO
• Pennington B, Hernandez-Alava M, Pudney S & Wailoo A (2018) The Impact of Moving from EQ-5D-3L to -5L in NICE Technology Appraisals. PharmacoEconomics. View this article in WRRO
• Hernandez M & pudney S (2018) EQ5DMAP: a command for mapping between EQ-5D-3L and EQ-5D-5L. The Stata journal, 18(2), 395-415. View this article in WRRO
• Gray LA, Hernandez M & Wailoo AJ (2018) Development of Methods for the Mapping of Utilities Using Mixture Models: Mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in Patients with Asthma. Value in Health, 21(6), 748-757. View this article in WRRO
• Gray LA, Hernandez M, Kelly M & Campbell M (2018) Family lifestyle dynamics and childhood obesity: evidence from the millennium cohort study. BMC Public Health, 18, 500-500. View this article in WRRO
• Gray LA & Alava MH (2018) A Command for Fitting Mixture Regression Models for Bounded Dependent Variables Using the Beta Distribution. The Stata Journal: Promoting communications on statistics and Stata, 18(1), 51-75. View this article in WRRO
• Hernandez Alava M, Wailoo A, Grimm S, Pudney S, Gomes M, Sadique Z, Meads D, O’Dwyer J, Barton G & Irvine L (2018) EQ-5D-5L versus EQ-5D-3L: The Impact on Cost-Effectiveness in the United Kingdom. Value in Health, 21(1), 49-56. View this article in WRRO
• Gibson LA, Hernandez M, Kelly M & Campbell M (2017) The effects of breastfeeding on childhood BMI: a propensity score matching approach. Journal of Public Health, 39(4), e152-e160. View this article in WRRO
• Hernandez-Alava M & Pudney S (2017) Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis. Journal of Health Economics, 55, 139-152. View this article in WRRO
• Stevenson MD, Wailoo AJ, Tosh JC, Hernandez-Alava M, Gibson LA, Stevens JW, Archer RJ, Simpson EL, Hock ES, Young A & Scott DL (2017) The Cost-effectiveness of Sequences of Biological Disease-modifying Antirheumatic Drug Treatment in England for Patients with Rheumatoid Arthritis Who Can Tolerate Methotrexate. Journal of Rheumatology, 44(7), 973-980. View this article in WRRO
• Hernandez-Alava M & Popli G (2017) Children’s Development and Parental Input: Evidence From the UK Millennium Cohort Study. Demography, 54(2), 485-511. View this article in WRRO
• Mukuria C, Rowen D, Hernández-Alava M, Dixon S & Ara R (2017) Predicting Productivity Losses from Health-Related Quality of Life Using Patient Data.. Applied Health Economics and Health Policy. View this article in WRRO
• Wailoo AJ, hernandez M, manca A, mejia A, Ray J, crawford B, botteman M & busschbach J (2017) Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report. Value in Health, 20(1), 18-27. View this article in WRRO
• Ward Fuller G, Hernandez M, Pallot D, Lecky F, Stevenson M & Gabbe B (2017) Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury: A Systematic Review and Mapping Study.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 20(1), 141-151. View this article in WRRO
• Stevenson M, Archer R, Tosh J, Simpson E, Everson-Hock E, Stevens J, Hernandez-Alava M, Paisley S, Dickinson K, Scott D , Young A et al (2016) Corrigendum: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation. Health Technology Assessment, 20(35), 611-614.
• Rowen D, Dixon S, Hernández-Alava M & Mukuria C (2016) Estimating informal care inputs associated with EQ-5D for use in economic evaluation. The European Journal of Health Economics, 17(6), 733-744. View this article in WRRO
• Stevenson M, Archer R, Tosh J, Simpson E, Everson-Hock E, Stevens J, Hernandez-Alava M, Paisley S, Dickinson K, Scott D , Young A et al (2016) Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation. Health Technology Assessment, 20(35), 1-610. View this article in WRRO
• Hernandez M & Pudney S (2016) Bicop: A Command for Fitting Bivariate Ordinal Regressions with Residual Dependence Characterized by a Copula Function and Normal Mixture Marginals. The Stata Journal, 16(1), 159-184. View this article in WRRO
• Wailoo A, Hernández M, Philips C, Brophy S & Siebert S (2015) Modeling Health State Utility Values in Ankylosing Spondylitis: Comparisons of Direct and Indirect Methods. Value in Health, 18(4), 425-431.
• Alava MH & Wailoo A (2015) Fitting Adjusted Limited Dependent Variable Mixture Models to EQ-5D. The Stata Journal: Promoting communications on statistics and Stata, 15(3), 737-750. View this article in WRRO
• Wailoo A, Hernandez Alava M, Scott IC, Ibrahim F & Scott D (2014) Cost-effectiveness of treatment strategies using combination disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritis. Rheumatology, 53(10), 1773-1777.
• Hernández Alava M, Wailoo A, Wolfe F & Michaud K (2014) A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes.. Med Decis Making, 34(7), 919-930.
• Wailoo A, Hernandez Alava M & Escobar Martinez A (2014) Modelling the relationship between the WOMAC Osteoarthritis Index and EQ-5D.. Health Qual Life Outcomes, 12, 37. View this article in WRRO
• Stevenson M, Gomersall T, Lloyd Jones M, Rawdin A, Hernández M, Dias S, Wilson D & Rees A (2014) Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost-effectiveness analysis.. Health Technol Assess, 18(17), 1-290.
• Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, Rowen D, Tosh J, Tsuchiya A, Evans P , Devianee Keetharuth A et al (2014) Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.. Health Technol Assess, 18(9), 1-224. View this article in WRRO
• Wailoo AJ, Hernandez M & Escobar Martinez A (2013) MODELLING THE RELATIONSHIP BETWEEN THE WO MAC OSTEOARTHRITIS INDEX AND EQ-5D. VALUE IN HEALTH, 16(7), A606-A606.
• Kearns B, Ara R, Wailoo A, Manca A, Alava MH, Abrams K & Campbell M (2013) Good practice guidelines for the use of statistical regression models in economic evaluations.. Pharmacoeconomics, 31(8), 643-652.
• Hernández Alava M, Wailoo A, Wolfe F & Michaud K (2013) The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis.. Rheumatology (Oxford), 52(5), 944-950. View this article in WRRO
• Alava MH, Brazier J, Rowen D & Tsuchiya A (2013) Common scale valuations across different preference-based measures: estimation using rank data.. Med Decis Making, 33(6), 839-852.
• Hernández Alava M, Wailoo AJ & Ara R (2012) Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values.. Value Health, 15(3), 550-561.
• Ara R, Blake L, Gray L, Hernández M, Crowther M, Dunkley A, Warren F, Jackson R, Rees A, Stevenson M , Abrams K et al (2012) What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.. Health Technol Assess, 16(5), iii-195.
• Rowen D, Brazier J, Tsuchiya A & Alava MH (2012) Valuing states from multiple measures on the same visual analogue sale: A feasibility study. Health Economics, 21(6), 715-729.
• Wailoo AJ, Hernandez M & Ara R (2011) MODELLING EQ-5D HEALTH STATE VALUES: DEVELOPING A LIMITED DEPENDENT VARIABLE, MIXTURE MODELING APPROACH. VALUE IN HEALTH, 14(7), A242-A242.
• Wailoo A, Goodacre S, Sampson F, Alava MH, Asseburg C, Palmer S, Sculpher M, Abrams K, de Belder M & Gray H (2010) Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty project.. Heart, 96(9), 668-672.
• Hernandez M, Pudney S & Hancock R (2007) The welfare cost of means-testing: Pensioner participation in income support. J APPL ECONOM, 22(3), 581-598. View this article in WRRO
• Hernandez M & Pudney S (2007) Measurement error in models of welfare participation. J PUBLIC ECON, 91(1-2), 327-341.
• Hancock R, Pudney S, Barker G, Hernandez M & Sutherland H (2004) The take-up of multiple means-tested benefits by British pensioners: Evidence from the family resources survey. Fiscal Studies, 25(3), 279-303.
• Hernández M (2002) A continuous time approach to cross country convergence. Contributions to Economics, 19-36.
• Wilson L, Bain M, Hernandez M, Holmes J, Pryce R, Sasso A, Stevely A, Warde A & Meier P () Solitary drinkers in Great Britain: How do their sociodemographic characteristics, consumption patterns, and drinking occasions differ from those who drink with others?. Journal of Studies on Alcohol and Drugs.
• Hernandez Alava M, Sasso A, Hnynn Si PE, Gittus M, Powell R, Dunn L, Thokala P & Fotheringham J () Relationship Between Standardized Measures of Chronic Kidney Disease-associated Pruritus Intensity and Health-related Quality of Life Measured with the EQ-5D Questionnaire: A Mapping Study. Acta Dermato-Venereologica, 103, adv11604-adv11604.
• Falk Hvidberg M & Hernández Alava M () Catalogues of EQ-5D-3L health-related quality of life scores for 199 chronic conditions and health risks for use in the UK and the USA. PharmacoEconomics.
• Franklin M & Hernández Alava M () Enabling QALY estimation in mental health trials and care settings: mapping from the PHQ-9 and GAD-7 to the ReQoL-UI or EQ-5D-5L using mixture models. Quality of Life Research.
• Hernández Alava M, Pudney SE & Wailoo AJ () Does EQ-5D Tell the whole story? Statistical methods for comparing the thematic coverage of clinical and generic outcome measures, with application to breast cancer. Value in Health.
• Thokala P, Hnynn Si PE, Hernandez Alava M, Sasso A, Schaufler T, Soro M & Fotheringham J () Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving Haemodialysis. PharmacoEconomics.
• Hvidberg M, Hernandez M, Petersen K, Davidsen M, Witt Udsen F, Frølich A & Ehlers L () Catalogue of EQ-5D-3L Health-Related Quality of Life Scores for 199 Chronic Conditions and Health Risks in Denmark. MDM Policy & Practice.
• Hernández Alava M, Wailoo A, Pudney S, Gray L & Manca A () Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods. Health Technology Assessment, 24(34), 1-68. View this article in WRRO
• Gray L, Hernandez M & Wailoo A () Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer. BMC Cancer.
• Poku E, Harnan S, Rooney G, James MM-S, Hernandez M, Schaufler T, Thokala P & Fotheringham J () The relationship between chronic kidney disease associated pruritus and health-related quality of life: a systematic review. Clinical Kidney Journal.
• Wailoo A, Hernandez M, Chrysanthou G, Barcelos F, van Gaalen F, Santos H, Fagerli K, Gago L, Margarida Cunha M, van de Sande M , Couto M et al () MEASURING QUALITY OF LIFE OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS FOR ECONOMIC EVALUATION. RMD Open.

Chapters

• Hernandez M (2019) From Clinical Outcomes to Health Utilities: The Role of Mapping to Bridge the Evidence Gap In Hamilton J (Ed.), Oxford Research Encyclopedia of Economics and Finance. OUP View this article in WRRO

Conference proceedings papers

• Thokala P, Si PEH, Hernandez M, Sasso A, Schaufler T, Soro M & Fotheringham J (2024) Cost-Effectiveness of Difelikefalin compared to Standard Care for treating Chronic Kidney Disease Associated Pruritus (CKD-aP). MEDICAL DECISION MAKING, Vol. 44(2) (pp NP160-NP160)
• Stevely A, Holmes J, Sasso A, Alava MH, Warde A, Angus C & Meier P (2023) OP54 Change and stability in British adults’ drinking practices and culture between 2009 and 2019: A longitudinal latent class analysis. SSM Annual Scientific Meeting
• Si PEH, Hernandez M, Sasso A, Gittus M, Powell R, Dunn L & Fotheringham J (2023) CKD-ASSOCIATED PRURITUS SEVERITY AND ITS ASSOCIATION WITH BODY DISTRIBUTION AND EQ-5D HEALTH-RELATED QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS. NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol. 38 (pp I760-I760)
• Franklin M, Porter A, de Vocht F, Kearns B, Latimer N, Hernandez M, Young T & Kidger J (2023) COMBINING CAUSAL INFERENCE AND WITHIN-TRIAL ECONOMIC EVALUATION METHODS TO ASSESS THE COST-EFFECTIVENESS OF A MENTAL HEALTH SERVICE USING REAL-WORLD DATA: THE QUASI-EXPERIMENTAL ADAPT STUDY. VALUE IN HEALTH, Vol. 26(12) (pp S87-S87)
• Geue C, Hawkins N, Oakley JE, Grieve R, Hernandez M & Carpenter J (2022) A FRAMEWORK FOR EXPERT ELICITATION RELATED TO COUNTERFACTUAL VALUES: A CASE STUDY OF ELICITATION TO INFORM SUBGROUP ANALYSES IN CLINICAL TRIALS. VALUE IN HEALTH, Vol. 25(1) (pp S274-S274)
• Si PEH, Hernandez M, Dunn L, Wilkie M & Fotheringham J (2022) SYMPTOM IMPROVEMENT WITH STANDARD CARE IN PEOPLE RECEIVING HAEMODIALYSIS ACROSS A RANGE OF SYMPTOMS IN THE POS-S RENAL: CONSIDERATION FOR CLINICAL PRACTICE AND TRIAL DESIGN. NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol. 37 (pp I619-I620)
• Geue C, Hawkins N, Oakley J, Grieve R, Hernandez M & Carpenter J (2020) A FRAMEWORK FOR EXPERT ELICITATION TO INFORM SUBGROUP ANALYSES IN CLINICAL TRIALS. MEDICAL DECISION MAKING, Vol. 40(5) (pp E410-E411)
• Hawkins N, Geue C, Oakley J, Grieve R & Hernandez M (2020) AN EXPLORATION OF THE TRADE-OFF BETWEEN FALSE NEGATIVES AND FALSE POSITIVES WHEN IDENTIFYING SUBGROUP EFFECTS. MEDICAL DECISION MAKING, Vol. 40(1) (pp E266-E267)
• Pennington B, Alshreef A, Flight L, Hykin P, Sivaprasad S, Brazier JE & Hernández M (2019) PSS25 Mapping from visual acuity to utility in patients with macular oedema due to central retinal vein occlusion using data from the LEAVO trial. Value in Health, Vol. 22(Suppl. 3) (pp S891-S891). Copenhagen, Denmark, 2 November 2019 - 6 November 2019. View this article in WRRO
• Pennington B, Alshreef A, Flight L, Hykin P, Sivaprasad S, Brazier JE & Hernandez M (2019) MAPPING FROM VISUAL ACUITY TO UTILITY IN PATIENTS WITH MACULAR OEDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION USING DATA FROM THE LEAVO TRIAL. VALUE IN HEALTH, Vol. 22 (pp S891-S891)
• Wailoo AJ, Stevenson M, Tosh J, Hernández M, Stevens JW, Archer R, Simpson E, everson HE, Scott D, Young A , Paisley S et al (2014) PMS41 The Cost-Effectiveness of Biologic Dmards in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional Dmards. Value in Health, Vol. 17(7) (pp a380)

Reports

• Hernandez M & Pudney SE (2016) Copula-based modelling of self-reported health states: An application to the use of EQ-5D-3L and EQ-5D-5L in evaluating drug therapies for rheumatic disease

Scholarly editions

• Rowen D, Brazier J, Tsuchiya A, Hernández M & Ibbotson R (2009) The simultaneous valuation of states from multiple instruments using ranking and VAS data: methods and preliminary results.

Posters

• Geue C, Hawkins N, Oakley JE, Grieve R, Hernandez M & Carpenter J (2022) POSB421 A Framework for Expert Elicitation Related to Counterfactual Values: A Case Study of Elicitation to Inform Subgroup Analyses in Clinical Trials..
• Mukuria C, Dixon S, Rowen D & Hernandez M Examining productivity losses associated with health related quality of life using patient data (2014).

Working papers

• Hernandez M & Pudney S () What you don't see can't hurt you? Panel data analysis and the dynamics of unobservable factors. View this article in WRRO
• Hernandez M, Pudney S & Hancock R () The welfare cost of means-testing: pensioner participation in income support.
• Pudney S, Hernandez M & Hancock R () The Welfare Cost of Means-Testing: Pensioner Participation in Income Support.
• Pudney S, Hernandez M & Hancock R () The Welfare Cost of Means-Testing: Pensioner Participation in Income Support.

Datasets

• Pennington R, Hernandez M, Hykin P, Sivaprasad S, Flight L, Alshreef A & Brazier J Utility calculator for visual acuity.

Presentations

• Hernandez M, Wailoo A, Chrysanthou G, Carvalho P, Van der Heijde D, Santos MJ & Machado PM OP0078 MAPPING FROM THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE (ASDAS) TO EQ5D IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS.

Preprints

• Worboys HM, Gray LJ, Burton JO, Alava MH & Cooper NJ (2023) Estimating EQ-5D-5L Utility Scores from the KDQoL-36 in Patients Undergoing Haemodialysis: A Mapping Algorithm for Economic Evaluation, Research Square Platform LLC.
• Franklin M, Porter A, De Vocht F, Kearns B, Latimer N, Alava MH, Young T & Kidger J (2023) Combining causal inference and within-trial economic evaluation methods to assess comparative cost-effectiveness using real-world data: a tutorial with recommendations based on the quasi-experimental ADAPT study of a redesigned mental health service.
• Holmes J, Sasso A, Alava MH, Neves RB, Stevely AK, Warde A & Meier PS (2023) Alcohol consumption and heavy episodic drinking within different types of drinking occasion in Great Britain: An event-level latent class analysis, Cold Spring Harbor Laboratory.